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Abstract
Purpose: We present a case of metastatic pulmonary calcification (MCP) in an asymptomatic patient with chronic 
kidney disease after renal transplantation and nephrectomy due to renal cancer. Chest computed tomography (CT) 
revealed bilateral, diffuse, centrilobular ground-glass opacities and heterogeneous, high-density areas distributed 
throughout the lungs, predominantly in the upper and middle lobes. Unusually, in our patient the metastatic calci-
fication coexisted with pulmonary metastases from renal cell carcinoma associated with end-stage renal disease. To 
our knowledge, such coexistence has not been previously described.
Case report: CT, particularly high-resolution chest computed tomography (HRCT), plays an important role in detection 
and follow-up of MPC findings, which include ground-glass opacities and partially calcified nodules or consolidations, 
predominantly in the upper lung zones. Correct diagnosis is important because misdiagnosis may lead to improper or 
unnecessary treatment and/or procedures.
Conclusions: MPC is a rare condition that results from calcium deposition in the normal pulmonary parenchyma. MPC 
commonly occurs in patients with end-stage chronic kidney disease due to abnormalities in calcium and phosphate 
metabolism. It is worth pointing out that despite the fact that the condition is called metastatic, it is a relatively benign 
lung disease with a generally good long-term prognosis.
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Introduction
Metastatic pulmonary calcification (MPC) is a rare metabolic 
lung disease that is commonly associated with chronic renal 
failure; however, it is rarely diagnosed antemortem. Depo-
sition of calcium salts in the interstitium and parenchyma 
of the lungs is a characteristic manifestation of MPC [1,2].
MPC occurs usually due conditions causing hyper-
calcemia. It may have a benign or malignant etiology. 
Benign etiologies include end-stage chronic kidney dis-
ease, primary and secondary hyperparathyroidism, exces-
sive exogenous administration of calcium and vitamin D, 
osteo porosis, sarcoidosis, milk-alkali syndrome, Paget’s 
disease, renal [1] or liver transplantation [1,3], and cardiac 
surgery [4].
Among malignant etiologies, multiple myeloma is the 
most common cause of cancer-related hypercalcemia, which 
is seen in 20-30% of cases [5,6]. Rarely, MPC occurs in pa-
tients with leukemia [7,8]. Other malignant causes include 
parathyroid carcinoma [5,9], lymphoma, breast carcinoma, 
choriocarcinoma, malignant melanoma, synovial carcino-
ma, and hypopharyngeal squamous cell carcinoma [1,5].
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The majority of patients with MPC are asymptomatic, but 
several cases of respiratory failure have been reported [5,7,9].
Patients with most severe manifestations have risk fac-
tors of MPC including intermittent imbalance of acidosis 
and alkalosis due to dialysis, and imbalance of calcium and 
phosphorus metabolism due to hyperparathyroidism [2]. 
MPC may occasionally appear in patients with normal re-
nal function, no underlying pulmonary disease, and nor-
mal calcium and phosphate levels [1].
Chest radiographs are not very sensitive in the de-
tection of MPC, and are usually normal or demonstrate 
patchy or confluent airspace opacities [10]. On high-reso-
lution computed tomography (HRCT), three patterns may 
be present as follows: patchy or diffuse areas of ground-
glass opacity or consolidation, multiple diffuse calcified 
nodules, and confluent high-attenuation parenchymal con-
solidation. These are relatively stable pulmonary changes, 
as opposed to infectious processes, and their resistance 
to medical therapy, in a clinical setting of elevated serum 
calcium levels, is of diagnostic value [1]. The aim of this 
report is to describe the radiological, clinical, and labora-
tory features in an asymptomatic patient with accidental 
MPC findings coexisting with pulmonary metastases from 
renal cell carcinoma. Moreover, we discuss this case in the 
context of the current literature.
Case report
A 55-year-old man with long-lasting chronic kidney disease 
due to glomerulonephritis and a 4-year history of hemo-
dialytic treatment underwent renal transplantation. He also 
underwent parathyroidectomy due to severe hyperparathy-
roid osteopathy with symptoms of sensorimotor polyneu-
ropathy, but the procedure did not relieve the symptoms.
The patient did not complain of fever, dyspnea or cough, 
there were no signs of an infectious focus, and previous 
plain chest radiographs were normal.
One of the routine follow-up abdominal ultrasound 
examinations, which was performed 14 years after renal 
transplantation, aroused the suspicion of renal tumor in 
the left cirrhotic kidney, which was confirmed on ab-
dominal CT. After nephrectomy, a histological diagnosis 
of renal cell carcinoma (clear cell carcinoma) was made. 
Follow-up abdominal CT revealed renal metastases in 
the right lower lung lobe and HRCT was planned subse-
quently. HRCT confirmed the presence of nodules, most 
likely metastatic, located mainly at the base of the lungs. 
Moreover, HRCT showed bilateral, diffuse, centrilobular 
ground-glass opacities and heterogeneous high-density 
areas distributed throughout the lungs, predominantly in 
the upper and middle lobes, with no apparent thickening 
of the interlobular septa, hilar, or mediastinal lymph node 
enlargement (Fig. 1). HRCT also showed vessel calcifi-
cations in the wall of the chest (Fig. 2B) and bronchial 
calcifications (Fig. 2A). The combination of pulmonary, 
vascular, and bronchial calcifications suggested metastatic 
pulmonary calcification.
Partial resection of the upper right pulmonary lobe was 
performed, which was most affected by the lesions. Both 
renal metastases and MPC were histologically confirmed. 
Afterwards, chemotherapy was initiated, and after four cy-
cles of pazopanib follow-up HRCT revealed partial regres-
sion of the metastatic nodules; however MPC was stable.
Retrospectively, on previous abdominal CT examina-
tions discrete, diffuse, centrilobular ground-glass opacities 
were also visible bilaterally in the lower parts of the lungs 
and had slightly worsened within 2 years (Fig. 3).
The laboratory results performed over the previous 
years showed slight hypercalcemia (serum calcium lev-
els up to 10.8 [normal, < 10.6 mg/dl]) and hyperparathy-
roidism (parathyroid hormone levels up to 151.9 pg/ml 
[normal, < 72 pg/ml]). Phosphate levels were normal. Kid-
ney function tests showed mildly elevated urea (up to 80 
mg/dl) and creatinine (up to 1.84 mg/dl) levels, and reduced 
glomerular filtration rate (down to 41 ml/min/1.73 m3). 
Figure 1. High-resolution chest computed tomography of the lungs. Meta-
static pulmonary calcification: A) axial scan of the upper lungs shows bilat-
eral, symmetrical, diffuse, indistinct, centrilobular ground-glass opacities 
with sparing of the periphery of the lobule and interlobular septa, B) coro-
nal reformation shows predominantly upper and middle lung distribution 
of opacities
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Arterial blood gas studies, apart from decreased oxygen 
saturation (90.5%) and decreased arterial oxygen tension 
(pO2), were normal.
Discussion
MPC is an underdiagnosed metabolic lung disease that is 
commonly associated with chronic renal failure [2]. Histo-
logical changes of MPC are seen at autopsy in 60-75% of 
patients who were previously treated with hemodialysis, 
although the condition was rarely recognized antemortem, 
probably due to inadequate sensitivity of standard chest ra-
diographs [1,10]. Pathologically, MPC is characterized by 
calcium salt deposition in basement membranes of the ep-
ithelium and endothelium of pulmonary alveoli. Soft tissue 
calcifications may also affect the stomach, heart, and kidneys, 
but the lung is the most frequently affected organ [1,7,9].
Most patients with MPC are asymptomatic; howev-
er, this condition occasionally may cause severe dyspnea, 
chronic, non-productive cough, hypoxemia, hemoptysis, 
and rarely alveolar hemorrhage [2,11]. Several reports de-
scribed acute respiratory failure that led to death [5,7,9]. 
The severity of respiratory symptoms often does not 
correlate with the degree of macroscopic calcifications. 
Patients with extensive calcifications may have no respirato-
ry symptoms, whereas those with minor changes or normal 
chest radiographs might sometimes have severe respiratory 
distress. Despite the fact that MPC generally develops over 
a long period of time, it can also progress rapidly within 
several weeks to months [2].
Metastatic, as opposed to dystrophic, pulmonary calci-
fications occur in normal pulmonary tissue without prior 
Figure 2. High-resolution chest computed tomography of the lungs. Accom-
panying findings of metastatic pulmonary calcification: (A) coronal reforma-
tion shows calcifications (arrows) in the walls of the trachea and bronchi, 
(B) axial scan shows calcifications (arrow) in a vessel of the chest wall
Figure 3. Follow-up computed tomography (CT) examinations. Slight pro-
gression of diffuse, centrilobular ground-glass opacities is visible bilaterally 
in the lower parts of the lungs due to metastatic pulmonary calcification, 
assessed retrospectively – (A) baseline CT, (B) follow-up CT after 1 year, 
(C) follow-up high-resolution chest computed tomography after 2 years 
(arrows show progression of metastases of renal carcinoma, *diaphragm)
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tissue damage, mainly due to alterations in calcium and 
phosphorus metabolism and an alkaline environment [1]. 
The primary pathogenic mechanism of MPC is still unex-
plained, but some factors, such as hypercalcemia (often 
due to hyperparathyroidism), hyperphosphatemia (as 
a result of hyperparathyroidism or reduced glomerular 
filtration rate), dialysis-associated intermittent acid-base 
imbalance, and local secretion of free hydrogen ions in the 
lungs, kidneys, and stomach have been suggested as the 
risk factors for MPC formation. Nevertheless, no correla-
tion has been described with the levels of calcium or par-
athyroid hormone, history of parathyroidectomy, duration 
of hemodialysis, and type of dialysate [2,12].
Our patient had several factors that predisposed to 
MPC including hypercalcemia, hyperparathyroidism, 
chronic kidney failure, and history of hemodialysis.
Pulmonary CT, and particularly HRCT, has higher 
sensitivity for MPC detection than chest radiography, de-
creasing the need for open lung biopsy [2,6]. The pattern 
of involvement might show a predilection of metastatic 
calcifications for the upper lung lobes due to increased 
alkalinity at the apices, which leads to higher deposition 
of calcium salts in this location [2].
Several CT patterns of MPC have been documented 
to date, such as multiple, diffuse calcified nodules that are 
either distributed throughout the entire lung or show a pre-
dilection to the apices, diffuse or patchy areas of ground-
glass opacity or consolidation, and confluent, high-atten-
uation parenchymal consolidation with a predominantly 
lobar distribution, mimicking lobar pneumonia or edema. 
Bronchial wall thickening or inter-lobular septal thickening 
and tree-in-bud appearance are not observed in MPC [1].
The presence of centrilobular ground-glass nodular 
opacities, with multiple poorly defined and fluffy nodules 
measuring 3-10 mm in diameter, with or without foci of 
calcification, is the most common parenchymal finding on 
HRCT [10]. The peripheral regions of the alveoli tend to 
become alkalized in comparison to the central area, which 
may explain the characteristic distribution of ground-glass 
attenuation areas[1].
Vessel calcifications in the wall of the chest are frequent-
ly associated with MPC, and sometimes calcifications are 
also visible in the bronchial walls. A combination of pulmo-
nary, vascular, and bronchial calcifications narrows down 
the differential diagnosis of pulmonary calcifications [10].
In our patient, HRCT showed typical MPC findings such 
as bilateral, diffuse, centrilobular ground-glass opacities and 
heterogeneous high-density areas distributed throughout the 
lungs, predominantly in the upper and middle lobes, vessel 
calcifications in the wall of the chest, and bronchial calcifi-
cations. The most unusual characteristic of our patient was 
the coexistence of metastatic calcification with pulmonary 
metastases from renal cell carcinoma of cirrhotic kidney. To 
our knowledge, this has not been previously described.
Radionuclide imaging with technetium-99m-meth-
ylene diphosphonate (Tc99 m-MDP) is a sensitive and 
specific technique for an early detection of MPC [2]. 
Lung areas affected by MPC demonstrate increased and 
generally symmetrical uptake of the radioactive isotope 
[1]. Bronchoscopy performed in patients with MPC may 
reveal multiple nodular and linear lesions at the surface of 
the trachea and the main bronchi, with submucosal calci-
fications confirmed on biopsy [13,14].
The majority of patients with asymptomatic, non-pro-
gressive MPC and renal failure do not require intervention. 
Although an optimal therapy of MPC has not been estab-
lished, the mainstay of treatment is normalization of calci-
um and phosphate levels, primarily with phosphate binders. 
Furthermore, bisphosphonates are suggested to normal-
izethe calcium level and to stop progression of calcifications 
in hypercalcemic patients [1,12]. Parathyroidectomy is in-
dicated in patients with life-threatening and uncontrollable 
pulmonary calcifications associated with hyperparathy-
roidism [9]. Renal transplantation may be considered for 
eligible patients. Several authors have noted reduction in 
calcifications, but there are also reports of dramatic progres-
sion of calcifications after transplantation [11], particularly 
after failed renal grafting [2,12].
The differential diagnosis of MPC includes all diseases 
that may lead to small, diffuse, calcified nodules, or small, 
diffuse, high-attenuation non-calcified nodules, and high-at-
tenuation consolidations. Causes of small, diffuse, calcified 
nodules include infection (histoplasmosis and mycobacterial 
infections), pulmonary metastases (chondrosarcoma, osteo-
sarcoma, mucin-producing adenocarcinomas, and papillary 
thyroid cancer), occupational and deposition diseases (coal 
workers’ pneumoconiosis, silicosis, siderosis), chronic hem-
orrhagic conditions (hemosiderosis), and idiopathic disor-
ders such as pulmonary alveolar microlithiasis [1]. If HRCT 
findings of MPC are diffuse, predominantly interstitial, and 
occasionally present as air-space opacities, they are often 
misdiagnosed as pneumonia or pulmonary edema. Lobar 
pneumonia, depending on its severity, may have a pattern of 
focal ground-glass opacity in a lobe or segment of the lung 
or dense opacification of the entire lobe. Similar bilateral 
patterns may appear in the course of pulmonary edema [3].
Conclusions
Metastatic pulmonary calcification (MPC) is often asymp-
tomatic and underdiagnosed, which may lead to irreversi-
ble damage of the lungs and respiratory failure. Therefore, 
radiologists must be able to identify the imaging patterns of 
this condition. HRCT is the method of choice for detecting 
MPC, and may obviate the need for open lung biopsy. MPC 
should be considered when dialysis patients with chronic 
kidney failure develop unusual HRCT changes such as pul-
monary infiltrates containing calcium depositions.
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